The effect of obesity on pathological complete response and survival in breast cancer patients receiving uncapped doses of neoadjuvant anthracycline-taxane-based chemotherapyAlex Farr, Christian F. Singer, Michael Seifert et al.|The Breast|2017Cited by 35
Correlation Between Preoperative Radiological and Postoperative Pathological Tumor Size in Patients With HER2+ Breast Cancer After Neoadjuvant Chemotherapy Plus Trastuzumab and PertuzumabVeronica Falcone, Georg Pfeiler, Elisabeth Reiser et al.|Clinical Breast Cancer|2021Cited by 2
HER2/CEP17 ratio predicts residual cancer burden after neoadjuvant dual HER2 blockade: real-world data in patients with primary HER2-amplified breast cancerMyriam Stolz, Zsuzsanna Bagó-Horváth, Rupert Bartsch et al.|Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin|2025Cited by 1